UPDATE
: Friday, December 6, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea, Peru compare notes on telemedicine
Government and industry officials from Korea and Peru gathered for the 5th ...
by Lee Han-soo
|
2019-10-08 15:20
라인
Propofol abuse, addiction increasing at alarming rate
A Ministry of Food and Drug Safety report has shown that more than 160,000 ...
by Lee Han-soo
|
2019-10-07 17:56
라인
Civic group protests regulator’s inaction over insulin pumps FDA recalled
A civic group supporting diabetic patients said it would hold a rally to pr...
by Lee Hye-seon
|
2019-10-07 16:10
라인
Regulator under fire for neglecting reported side effects of Invossa
The Ministry of Food and Drug Safety has come under criticism for doing lit...
by Lee Han-soo
|
2019-10-04 14:59
라인
Foreign patients visiting Korea rise by 17.8% in 2018
The number of foreigners getting medical treatment in Korea increased last ...
by Lee Han-soo
|
2019-10-02 17:50
라인
Authorities to test drugs of ranitidine family for carcinogen risk
The Ministry of Food and Drug Safety said it might test all stomach medicin...
by Lee Hye-seon
|
2019-10-02 14:51
라인
Regulator raids cell therapy makers too often to little avail
In the wake of the recall of cell gene therapy Invossa-K, the Ministry of F...
by Jeong Sae-im
|
2019-10-02 11:23
라인
Cost of smartphone-related illness tops ₩400 billion in 2018
Medical expenses to treat smartphone-related diseases such as dry eye syndr...
by Lee Han-soo
|
2019-10-01 15:47
라인
Will parliamentary audit uncover why Invossa was mislabeled?
The National Assembly’s Health and Welfare Committee is expected to focus o...
by Jeong Sae-im
|
2019-10-01 15:45
라인
Drug regulator under fire for going too far, too late
The Ministry of Food and Drug Safety (MFDS)'s ability and credibility a...
by Lee Han-soo
|
2019-09-27 17:48
라인
Foreign trainees satisfied with Lee Jong-wook Fellowship
The Lee Jong-wook Fellowship is receiving favorable feedback from trainees ...
by Choi Gwang-seok
|
2019-09-27 15:05
라인
Regulator explained why it banned stomach medicine ranitidine altogether
The Ministry of Food and Drug Safety Thursday offered a briefing to pharmac...
by Jeong Sae-im
|
2019-09-27 15:02
라인
Ranitidine heartburn drugs banned due to carcinogen risk
The Ministry of Food and Drug Safety has suspended the manufacturing and se...
by Lee Hye-seon
|
2019-09-26 13:32
라인
Korea, Uzbekistan speed up public health cooperation
Korea will accelerate cooperation with Uzbekistan in public health, initiat...
by Kwak Sung-sun
|
2019-09-25 15:26
라인
Ministry to announce results of ranitidine testing for carcinogen
The government is likely to announce the results of the test on ranitidine ...
by Lee Hye-seon
|
2019-09-25 14:46
라인
Ministry advises smokers to stop using e-cigarettes
The Ministry of Health and Welfare has recommended smokers who use e-cigare...
by Lee Han-soo
|
2019-09-23 16:55
라인
Sex-specific strategies needed to prevent dementia
Men and women have different cardiometabolic risk factors that could lower ...
by Kwak Sung-sun
|
2019-09-20 14:30
라인
Korea unlikely to include hepatitis C test in state-backed health checkup
The government is unlikely to designate a hepatitis C antibody test as a he...
by Kim Yun-mi
|
2019-09-18 15:50
라인
Regulator delays decision on delisting Kolon TissueGene
The Korea Exchange said it has delayed its decision whether to delist Kolon...
by Jeong Sae-im
|
2019-09-18 14:27
라인
Korea narrows pharmaceutical trade gap in 5 years
Korea's deficit in pharmaceuticals trade has been on the decline for th...
by Lee Han-soo
|
2019-09-18 11:38
-
1
2
3
4
5
6
7
8
9
10
다음
-
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
Syntekabio, CHA Hospital to co-develop immunotherapy
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
Syntekabio, CHA Hospital to co-develop immunotherapy
여백
Most viewed
1
Technology developed to detect inflammatory disorders early
2
‘Obesity needs to be treated as a chronic disease’
3
Alteogen inks licensing-out deal for SC injection formulation technology
4
'Insulin is safe, natural replacement therapy for diabetic patients'
5
Samyang Biopharm’s US subsidiary to work on new immunotherapy
6
Swedish researchers divide Type 2 diabetes into 5 subgroups
7
Ildong signs co-promotion contract with GSK Consumer Healthcare
8
‘Korea is lagging behind China in healthcare’
9
LG Chem licenses in US firm’s diagnostic platform tech
10
Korean patient with rare breast cancer to sue Allergan in US
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top